| 6.8 |
27.1 |
GO:0051796 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 5.6 |
22.4 |
GO:0003169 |
coronary vein morphogenesis(GO:0003169) |
| 5.4 |
16.1 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 5.3 |
21.3 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 5.3 |
5.3 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 4.9 |
14.6 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 4.7 |
14.2 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 4.6 |
22.8 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 4.3 |
12.9 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 4.3 |
59.9 |
GO:0035290 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 4.1 |
4.1 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 4.1 |
20.6 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 3.9 |
15.8 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 3.9 |
19.7 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 3.6 |
14.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 3.5 |
20.8 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 3.5 |
3.5 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 3.4 |
3.4 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 3.4 |
10.1 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 3.4 |
20.1 |
GO:0030421 |
defecation(GO:0030421) |
| 3.3 |
13.3 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 3.3 |
19.7 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 3.2 |
13.0 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 3.2 |
9.6 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 3.1 |
9.4 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 3.1 |
12.4 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 3.1 |
9.2 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 3.0 |
30.5 |
GO:1901315 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 3.0 |
9.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 3.0 |
9.1 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 3.0 |
12.0 |
GO:1903381 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 3.0 |
6.0 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 2.9 |
8.7 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 2.9 |
2.9 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 2.8 |
8.5 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 2.8 |
11.4 |
GO:0016334 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 2.8 |
11.2 |
GO:1904501 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 2.8 |
8.3 |
GO:1903515 |
calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 2.8 |
11.1 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 2.8 |
2.8 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 2.7 |
13.5 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 2.6 |
23.5 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 2.6 |
23.3 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 2.6 |
28.2 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 2.5 |
32.2 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 2.4 |
7.3 |
GO:1903249 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 2.4 |
11.9 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 2.4 |
7.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 2.4 |
2.4 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.3 |
9.4 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.3 |
16.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 2.3 |
6.9 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 2.3 |
6.9 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 2.3 |
6.9 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 2.3 |
13.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 2.3 |
33.9 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 2.2 |
17.9 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 2.2 |
15.7 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 2.2 |
2.2 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 2.2 |
6.7 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 2.2 |
8.8 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 2.2 |
33.0 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 2.2 |
10.9 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 2.2 |
6.5 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 2.2 |
6.5 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 2.1 |
15.0 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 2.1 |
2.1 |
GO:0032353 |
negative regulation of hormone biosynthetic process(GO:0032353) |
| 2.1 |
16.9 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 2.1 |
6.3 |
GO:1904351 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 2.1 |
2.1 |
GO:0061438 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
| 2.1 |
12.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 2.1 |
6.2 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 2.1 |
10.3 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 2.1 |
8.2 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 2.1 |
6.2 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 2.0 |
30.6 |
GO:0060613 |
fat pad development(GO:0060613) |
| 2.0 |
10.2 |
GO:0021623 |
optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 2.0 |
10.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 2.0 |
14.2 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 2.0 |
32.3 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 2.0 |
6.1 |
GO:0034147 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 2.0 |
6.0 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 2.0 |
4.0 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 2.0 |
6.0 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 2.0 |
6.0 |
GO:2000656 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 2.0 |
7.9 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 2.0 |
7.8 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 1.9 |
11.7 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.9 |
5.8 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 1.9 |
7.7 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 1.9 |
3.8 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.9 |
7.6 |
GO:1904800 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.9 |
5.7 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 1.9 |
15.1 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 1.9 |
7.5 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 1.9 |
13.0 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 1.8 |
9.2 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 1.8 |
7.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.8 |
3.7 |
GO:0009216 |
purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 1.8 |
5.4 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.8 |
10.7 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 1.8 |
8.9 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.8 |
5.3 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.8 |
28.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 1.7 |
1.7 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 1.7 |
32.6 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 1.7 |
6.8 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 1.7 |
10.1 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 1.7 |
23.5 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.7 |
1.7 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 1.7 |
6.7 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 1.7 |
10.0 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 1.7 |
11.6 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 1.7 |
1.7 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 1.7 |
5.0 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.7 |
5.0 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 1.6 |
16.4 |
GO:1904379 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.6 |
9.8 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 1.6 |
17.7 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.6 |
1.6 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 1.6 |
9.6 |
GO:0042335 |
cuticle development(GO:0042335) |
| 1.6 |
6.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 1.6 |
4.8 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.6 |
27.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 1.6 |
4.8 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 1.6 |
36.3 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 1.6 |
11.0 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 1.6 |
1.6 |
GO:0060948 |
cardiac vascular smooth muscle cell development(GO:0060948) |
| 1.6 |
17.2 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 1.6 |
23.4 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.6 |
9.3 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 1.5 |
1.5 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 1.5 |
3.1 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 1.5 |
4.6 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 1.5 |
9.2 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 1.5 |
12.3 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 1.5 |
6.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 1.5 |
9.2 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 1.5 |
3.0 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 1.5 |
1.5 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 1.5 |
42.5 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 1.5 |
4.5 |
GO:0051258 |
protein polymerization(GO:0051258) |
| 1.5 |
10.6 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 1.5 |
6.0 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 1.5 |
1.5 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 1.5 |
3.0 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 1.5 |
17.7 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 1.5 |
17.7 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 1.5 |
4.4 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 1.5 |
1.5 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.5 |
5.9 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 1.5 |
13.2 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 1.5 |
7.3 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 1.5 |
1.5 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 1.5 |
37.9 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.5 |
1.5 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 1.5 |
4.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.5 |
5.8 |
GO:0097156 |
fasciculation of motor neuron axon(GO:0097156) |
| 1.4 |
1.4 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 1.4 |
7.2 |
GO:1902904 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 1.4 |
2.9 |
GO:0061145 |
bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 1.4 |
1.4 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 1.4 |
14.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 1.4 |
4.2 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 1.4 |
4.2 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 1.4 |
1.4 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 1.4 |
11.2 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 1.4 |
2.8 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 1.4 |
4.1 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 1.4 |
13.7 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.4 |
4.1 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.3 |
4.0 |
GO:1903679 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.3 |
2.7 |
GO:2001038 |
regulation of cellular response to drug(GO:2001038) |
| 1.3 |
4.0 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 1.3 |
4.0 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 1.3 |
17.2 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 1.3 |
4.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 1.3 |
22.4 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 1.3 |
5.2 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 1.3 |
3.9 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 1.3 |
18.2 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 1.3 |
1.3 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 1.3 |
1.3 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 1.3 |
5.1 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 1.3 |
3.8 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 1.3 |
5.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.3 |
2.5 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 1.3 |
5.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 1.3 |
3.8 |
GO:0072684 |
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 1.3 |
3.8 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 1.2 |
10.0 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.2 |
6.2 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 1.2 |
3.7 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 1.2 |
7.4 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 1.2 |
1.2 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 1.2 |
4.9 |
GO:2000980 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.2 |
1.2 |
GO:1903233 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 1.2 |
6.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.2 |
8.5 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 1.2 |
6.1 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.2 |
8.4 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 1.2 |
2.4 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 1.2 |
2.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.2 |
8.4 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 1.2 |
3.6 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 1.2 |
4.8 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 1.2 |
3.6 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.2 |
4.7 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 1.2 |
7.0 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 1.2 |
1.2 |
GO:0007051 |
spindle organization(GO:0007051) |
| 1.2 |
4.7 |
GO:0036016 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.2 |
3.5 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 1.2 |
5.8 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
| 1.2 |
9.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 1.2 |
22.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 1.2 |
2.3 |
GO:2000681 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 1.2 |
6.9 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.1 |
9.2 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.1 |
4.5 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 1.1 |
20.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 1.1 |
7.9 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 1.1 |
30.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 1.1 |
5.6 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 1.1 |
3.4 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 1.1 |
2.2 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 1.1 |
12.2 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.1 |
5.5 |
GO:0032796 |
uropod organization(GO:0032796) |
| 1.1 |
5.5 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 1.1 |
1.1 |
GO:0071877 |
regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 1.1 |
2.2 |
GO:0018065 |
protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
| 1.1 |
7.6 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.1 |
3.3 |
GO:0021776 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.1 |
6.5 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 1.1 |
3.3 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 1.1 |
27.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 1.1 |
20.5 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 1.1 |
6.5 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.1 |
3.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 1.1 |
11.8 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 1.1 |
3.2 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 1.1 |
7.5 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 1.1 |
5.3 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 1.1 |
3.2 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 1.1 |
4.2 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 1.1 |
2.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 1.1 |
7.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.1 |
3.2 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 1.0 |
3.1 |
GO:1904237 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.0 |
1.0 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 1.0 |
4.1 |
GO:0035522 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 1.0 |
4.1 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 1.0 |
1.0 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 1.0 |
11.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 1.0 |
14.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 1.0 |
9.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 1.0 |
5.1 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 1.0 |
7.1 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 1.0 |
8.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 1.0 |
8.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.0 |
4.0 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 1.0 |
5.0 |
GO:0051622 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 1.0 |
2.0 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 1.0 |
18.1 |
GO:0015816 |
glycine transport(GO:0015816) |
| 1.0 |
6.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.0 |
23.8 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 1.0 |
6.9 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 1.0 |
17.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.0 |
2.0 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 1.0 |
4.9 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 1.0 |
1.0 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 1.0 |
8.9 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.0 |
11.8 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.0 |
2.0 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 1.0 |
2.9 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 1.0 |
5.9 |
GO:0007032 |
endosome organization(GO:0007032) |
| 1.0 |
26.5 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 1.0 |
8.7 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 1.0 |
7.7 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.0 |
1.0 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 1.0 |
3.8 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 1.0 |
4.8 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.0 |
4.8 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.9 |
2.8 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.9 |
4.7 |
GO:0030807 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.9 |
13.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.9 |
2.8 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.9 |
1.9 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.9 |
0.9 |
GO:0060119 |
inner ear receptor cell development(GO:0060119) inner ear receptor stereocilium organization(GO:0060122) |
| 0.9 |
19.5 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.9 |
2.8 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.9 |
4.6 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.9 |
2.8 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.9 |
3.7 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.9 |
4.6 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.9 |
8.3 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.9 |
8.3 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.9 |
3.7 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.9 |
6.4 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.9 |
0.9 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.9 |
5.5 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.9 |
7.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.9 |
7.2 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.9 |
11.7 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.9 |
2.7 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.9 |
1.8 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 0.9 |
8.0 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.9 |
4.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.9 |
1.8 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.9 |
5.3 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 |
17.7 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.9 |
1.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.9 |
4.4 |
GO:0061528 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.9 |
4.4 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.9 |
17.6 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.9 |
2.6 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.9 |
6.2 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.9 |
32.5 |
GO:0060674 |
placenta blood vessel development(GO:0060674) |
| 0.9 |
9.6 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.9 |
1.7 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.9 |
7.8 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.9 |
2.6 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.9 |
6.0 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.9 |
3.4 |
GO:0006208 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.9 |
2.6 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.9 |
1.7 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.9 |
3.4 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.8 |
0.8 |
GO:0030038 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.8 |
5.1 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.8 |
2.5 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.8 |
3.3 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.8 |
5.0 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.8 |
2.5 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.8 |
3.3 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.8 |
1.7 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.8 |
2.5 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.8 |
2.5 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.8 |
0.8 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.8 |
1.6 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.8 |
1.6 |
GO:1904783 |
positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.8 |
4.9 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.8 |
2.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.8 |
2.4 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.8 |
16.2 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.8 |
0.8 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.8 |
3.2 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.8 |
3.2 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.8 |
4.0 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.8 |
4.0 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.8 |
17.6 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.8 |
6.4 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.8 |
24.6 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.8 |
4.8 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.8 |
4.7 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.8 |
15.0 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.8 |
3.1 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.8 |
8.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 |
5.5 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.8 |
13.3 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.8 |
0.8 |
GO:1901205 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.8 |
6.2 |
GO:0060051 |
negative regulation of protein glycosylation(GO:0060051) |
| 0.8 |
10.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.8 |
7.0 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.8 |
4.6 |
GO:1901911 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.8 |
3.1 |
GO:0071684 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.8 |
2.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.8 |
8.4 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.8 |
1.5 |
GO:2000452 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.8 |
2.3 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.8 |
9.8 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.8 |
1.5 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.8 |
0.8 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.8 |
6.0 |
GO:0048298 |
regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.8 |
3.8 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.8 |
2.3 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.7 |
3.0 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.7 |
2.2 |
GO:0045083 |
negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.7 |
1.5 |
GO:0051198 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.7 |
1.5 |
GO:0098779 |
mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.7 |
3.7 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.7 |
2.2 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.7 |
0.7 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.7 |
2.2 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.7 |
11.8 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.7 |
3.7 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.7 |
2.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.7 |
2.2 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.7 |
3.7 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.7 |
2.9 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.7 |
12.4 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.7 |
8.0 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.7 |
2.2 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.7 |
10.8 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.7 |
8.6 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.7 |
10.1 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.7 |
1.4 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.7 |
2.1 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.7 |
2.1 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.7 |
2.1 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.7 |
0.7 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.7 |
6.4 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.7 |
4.3 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.7 |
6.4 |
GO:0035733 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.7 |
2.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.7 |
2.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.7 |
2.1 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.7 |
2.1 |
GO:0070377 |
regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.7 |
0.7 |
GO:1903051 |
negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
| 0.7 |
7.0 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.7 |
2.1 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.7 |
7.7 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.7 |
2.8 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.7 |
22.3 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.7 |
2.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.7 |
4.8 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.7 |
2.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.7 |
9.7 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.7 |
1.4 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.7 |
19.2 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.7 |
1.4 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.7 |
16.4 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.7 |
2.7 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.7 |
0.7 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.7 |
2.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.7 |
6.1 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.7 |
14.3 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.7 |
2.7 |
GO:0031585 |
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 0.7 |
3.4 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.7 |
17.6 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.7 |
6.7 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.7 |
9.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.7 |
6.7 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.7 |
7.3 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.7 |
1.3 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.7 |
11.3 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.7 |
6.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.7 |
17.9 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.7 |
7.9 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.7 |
0.7 |
GO:0034331 |
cell junction maintenance(GO:0034331) |
| 0.7 |
2.0 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.7 |
2.6 |
GO:0097192 |
signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.7 |
9.2 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.7 |
2.0 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.6 |
1.9 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.6 |
3.9 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) |
| 0.6 |
0.6 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.6 |
1.9 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.6 |
41.0 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.6 |
4.5 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.6 |
0.6 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.6 |
14.1 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.6 |
1.3 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.6 |
5.8 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.6 |
2.5 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.6 |
11.5 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.6 |
3.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.6 |
1.9 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.6 |
3.2 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.6 |
7.0 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.6 |
2.5 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.6 |
15.0 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.6 |
0.6 |
GO:1903170 |
negative regulation of calcium ion transmembrane transport(GO:1903170) |
| 0.6 |
2.5 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.6 |
14.9 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.6 |
1.9 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 |
4.9 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.6 |
4.3 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.6 |
0.6 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.6 |
8.0 |
GO:0060004 |
reflex(GO:0060004) |
| 0.6 |
1.8 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.6 |
5.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.6 |
7.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.6 |
7.3 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.6 |
2.4 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.6 |
2.4 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.6 |
3.0 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.6 |
1.8 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.6 |
1.8 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.6 |
5.4 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.6 |
1.2 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.6 |
4.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 |
17.8 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.6 |
1.2 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.6 |
8.3 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.6 |
4.1 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.6 |
17.1 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.6 |
1.8 |
GO:1902722 |
positive regulation of prolactin secretion(GO:1902722) |
| 0.6 |
5.9 |
GO:0060717 |
chorion development(GO:0060717) |
| 0.6 |
6.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.6 |
1.8 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.6 |
6.4 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.6 |
2.9 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.6 |
1.7 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.6 |
1.7 |
GO:1905216 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.6 |
2.9 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.6 |
5.8 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.6 |
4.0 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.6 |
1.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.6 |
0.6 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.6 |
2.3 |
GO:0071901 |
negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.6 |
1.1 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.6 |
2.3 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.6 |
5.1 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.6 |
7.4 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.6 |
7.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.6 |
4.0 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.6 |
6.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.6 |
10.6 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.6 |
10.0 |
GO:1904261 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.6 |
2.2 |
GO:0060151 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.6 |
3.3 |
GO:0033029 |
regulation of neutrophil apoptotic process(GO:0033029) |
| 0.6 |
3.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.6 |
1.1 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.6 |
1.7 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.6 |
1.7 |
GO:2000742 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.5 |
0.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.5 |
3.3 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.5 |
6.0 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.5 |
1.1 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.5 |
0.5 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.5 |
1.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.5 |
1.1 |
GO:0046730 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 |
4.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.5 |
3.2 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 |
5.4 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.5 |
9.6 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.5 |
3.7 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.5 |
13.3 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.5 |
0.5 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.5 |
1.6 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.5 |
1.1 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.5 |
11.7 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.5 |
3.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.5 |
1.6 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 |
11.1 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.5 |
3.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.5 |
0.5 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.5 |
5.3 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.5 |
1.6 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.5 |
1.0 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.5 |
4.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 |
6.8 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.5 |
3.6 |
GO:0009188 |
purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.5 |
3.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.5 |
1.0 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.5 |
2.6 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.5 |
4.1 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.5 |
4.1 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.5 |
1.5 |
GO:0042245 |
RNA repair(GO:0042245) |
| 0.5 |
0.5 |
GO:0060993 |
kidney morphogenesis(GO:0060993) |
| 0.5 |
0.5 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.5 |
3.1 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.5 |
0.5 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.5 |
0.5 |
GO:0060545 |
positive regulation of necroptotic process(GO:0060545) |
| 0.5 |
1.0 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.5 |
1.5 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.5 |
3.5 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 |
2.5 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
| 0.5 |
7.5 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.5 |
19.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.5 |
15.0 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.5 |
0.5 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.5 |
3.5 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.5 |
3.5 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.5 |
3.0 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.5 |
4.5 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.5 |
3.0 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.5 |
0.5 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.5 |
8.8 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.5 |
3.4 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.5 |
1.5 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.5 |
1.5 |
GO:2000619 |
negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.5 |
3.9 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.5 |
2.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.5 |
7.8 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.5 |
5.8 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.5 |
1.5 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.5 |
13.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.5 |
2.4 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.5 |
3.8 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 |
1.4 |
GO:0071514 |
genetic imprinting(GO:0071514) |
| 0.5 |
6.6 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.5 |
0.9 |
GO:0032763 |
mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) negative regulation of mast cell cytokine production(GO:0032764) |
| 0.5 |
4.3 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.5 |
8.0 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.5 |
1.9 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.5 |
1.9 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.5 |
5.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.5 |
0.9 |
GO:0002582 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.5 |
1.4 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.5 |
3.3 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.5 |
2.3 |
GO:0045839 |
negative regulation of mitotic nuclear division(GO:0045839) |
| 0.5 |
3.7 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.5 |
2.3 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.5 |
0.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.5 |
17.4 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.5 |
3.7 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.5 |
1.4 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.5 |
3.7 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.5 |
3.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.5 |
2.7 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.5 |
2.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.4 |
7.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.4 |
6.3 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.4 |
16.0 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.4 |
6.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.4 |
2.7 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.4 |
5.7 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.4 |
1.7 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.4 |
21.3 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.4 |
0.9 |
GO:1903758 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.4 |
1.3 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.4 |
1.3 |
GO:0071790 |
spindle pole body duplication(GO:0030474) nuclear pore distribution(GO:0031081) spindle pole body organization(GO:0051300) nuclear pore localization(GO:0051664) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.4 |
14.3 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.4 |
3.5 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 |
2.6 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.4 |
0.9 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.4 |
4.7 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.4 |
3.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.4 |
3.4 |
GO:0070587 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.4 |
1.7 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 |
1.7 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.4 |
1.7 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.4 |
1.3 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.4 |
3.8 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.4 |
0.8 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.4 |
4.6 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.4 |
8.8 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.4 |
3.7 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.4 |
10.0 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.4 |
1.2 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 |
4.6 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.4 |
0.4 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.4 |
1.7 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.4 |
2.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.4 |
6.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.4 |
2.9 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.4 |
12.2 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.4 |
4.5 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.4 |
0.8 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.4 |
5.3 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.4 |
1.6 |
GO:0070895 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.4 |
27.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.4 |
2.0 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 |
2.8 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.4 |
1.2 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.4 |
3.6 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.4 |
12.9 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
2.0 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.4 |
0.4 |
GO:1900102 |
negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.4 |
1.6 |
GO:0036414 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 |
2.4 |
GO:0043697 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.4 |
2.0 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.4 |
2.0 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.4 |
1.6 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.4 |
1.9 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.4 |
2.3 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.4 |
4.3 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.4 |
1.6 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.4 |
2.7 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 |
13.6 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.4 |
2.3 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.4 |
4.2 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.4 |
3.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.4 |
2.3 |
GO:2000234 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.4 |
4.2 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.4 |
1.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 |
3.8 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
4.2 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.4 |
0.8 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.4 |
4.1 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) |
| 0.4 |
1.5 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.4 |
1.1 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 |
2.6 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.4 |
0.4 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.4 |
5.2 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.4 |
1.5 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 |
0.4 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.4 |
4.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.4 |
2.9 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.4 |
4.8 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 |
0.7 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.4 |
2.9 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.4 |
0.7 |
GO:0031943 |
regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.4 |
9.9 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 |
2.2 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.4 |
3.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.4 |
3.3 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.4 |
6.6 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.4 |
1.1 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.4 |
1.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.4 |
1.1 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.4 |
4.7 |
GO:1904903 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.4 |
2.5 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 0.4 |
4.0 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.4 |
2.2 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.4 |
1.1 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.4 |
3.6 |
GO:0031114 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.4 |
0.7 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.4 |
1.1 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.4 |
1.4 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.4 |
1.8 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.4 |
0.7 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.4 |
11.4 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.4 |
2.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.4 |
3.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.4 |
2.1 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.4 |
1.4 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.4 |
1.8 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.4 |
1.4 |
GO:0070444 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.4 |
1.8 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.4 |
0.7 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.4 |
1.8 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.3 |
0.3 |
GO:1904868 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.3 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.3 |
0.7 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.3 |
4.8 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
0.7 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.3 |
6.9 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.3 |
2.7 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.3 |
2.4 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.3 |
1.0 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 |
9.2 |
GO:0042921 |
glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.3 |
33.2 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.3 |
1.0 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.3 |
6.8 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 |
3.0 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 |
3.7 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 |
2.0 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.3 |
1.3 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.3 |
7.1 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.3 |
2.3 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.3 |
1.7 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.3 |
3.0 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.3 |
0.3 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 |
1.3 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.3 |
0.7 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.3 |
1.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.3 |
3.6 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.3 |
3.6 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.3 |
4.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.3 |
2.0 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.3 |
2.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
4.9 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.3 |
2.3 |
GO:1904550 |
chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.3 |
8.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 |
5.2 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.3 |
1.9 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 |
0.6 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.3 |
1.3 |
GO:0050992 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.3 |
2.9 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.3 |
1.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.3 |
6.8 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 |
3.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 |
2.6 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.3 |
1.0 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 |
1.9 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 |
0.3 |
GO:0070229 |
negative regulation of lymphocyte apoptotic process(GO:0070229) |
| 0.3 |
0.3 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.3 |
1.3 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.3 |
1.9 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.3 |
0.6 |
GO:0015883 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.3 |
2.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.3 |
0.6 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.3 |
0.3 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.3 |
1.3 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.3 |
38.7 |
GO:0070268 |
cornification(GO:0070268) |
| 0.3 |
0.3 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.3 |
3.7 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.3 |
19.2 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.3 |
2.7 |
GO:0021987 |
cerebral cortex development(GO:0021987) |
| 0.3 |
0.6 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.3 |
4.3 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.3 |
2.4 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.3 |
0.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.2 |
GO:1902510 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.3 |
0.6 |
GO:0021761 |
limbic system development(GO:0021761) |
| 0.3 |
1.2 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.3 |
2.1 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.3 |
3.0 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.3 |
1.2 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.3 |
6.0 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.3 |
4.2 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 |
12.8 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.3 |
3.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.3 |
0.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 |
1.8 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.3 |
1.2 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.3 |
49.8 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.3 |
2.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 |
1.2 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.3 |
2.6 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.3 |
2.1 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.3 |
2.0 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.3 |
2.9 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.3 |
1.2 |
GO:0032402 |
melanosome localization(GO:0032400) establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
| 0.3 |
2.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 |
1.5 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.3 |
1.4 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 |
1.4 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.3 |
4.0 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.3 |
1.1 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.3 |
1.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 |
1.7 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 |
3.7 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.3 |
5.7 |
GO:0046546 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.3 |
3.1 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.3 |
1.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.3 |
1.4 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 |
21.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.3 |
2.8 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
2.8 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.3 |
4.5 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.3 |
1.1 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.3 |
0.8 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.3 |
1.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.3 |
15.3 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.3 |
0.8 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 |
8.3 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.3 |
0.8 |
GO:0098939 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 |
0.3 |
GO:0051584 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.3 |
2.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.3 |
0.5 |
GO:1990418 |
response to insulin-like growth factor stimulus(GO:1990418) |
| 0.3 |
2.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.3 |
1.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 |
4.6 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.3 |
3.2 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
0.8 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 |
5.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.3 |
0.3 |
GO:0036093 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.3 |
0.8 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.3 |
3.9 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.3 |
2.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.3 |
0.5 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.3 |
1.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 |
4.7 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
0.8 |
GO:0060629 |
meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
| 0.3 |
0.3 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.3 |
0.8 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.3 |
0.3 |
GO:0044843 |
cell cycle G1/S phase transition(GO:0044843) |
| 0.3 |
1.8 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 |
3.5 |
GO:0019079 |
viral genome replication(GO:0019079) |
| 0.2 |
5.7 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 |
3.0 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
1.2 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.2 |
4.2 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 |
6.6 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 |
0.5 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 |
3.4 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
1.7 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.2 |
15.9 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 |
4.8 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 |
2.4 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.2 |
6.0 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.2 |
1.0 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
2.9 |
GO:0035376 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 |
1.2 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.2 |
2.6 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.2 |
0.2 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.2 |
1.9 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
3.8 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.2 |
1.7 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 |
3.1 |
GO:0032481 |
positive regulation of type I interferon production(GO:0032481) |
| 0.2 |
5.9 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 |
1.4 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 |
0.2 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.2 |
0.7 |
GO:0030100 |
regulation of endocytosis(GO:0030100) |
| 0.2 |
0.5 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.2 |
2.6 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.2 |
1.2 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 |
0.5 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
3.7 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.2 |
0.2 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.2 |
1.4 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
17.0 |
GO:0030819 |
positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.2 |
0.5 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 |
1.1 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.2 |
3.4 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.2 |
2.7 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.2 |
0.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
1.8 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
0.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.7 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.2 |
1.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.2 |
3.4 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.2 |
0.7 |
GO:0051126 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.2 |
0.9 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 |
1.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.2 |
1.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
0.4 |
GO:0019418 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 |
1.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.7 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 |
0.4 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.2 |
6.4 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.2 |
0.7 |
GO:0007343 |
egg activation(GO:0007343) female pronucleus assembly(GO:0035038) |
| 0.2 |
2.0 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.7 |
GO:1901623 |
regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.2 |
0.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.2 |
0.6 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 |
1.9 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.2 |
0.9 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.2 |
1.3 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.2 |
1.5 |
GO:0050688 |
regulation of defense response to virus(GO:0050688) |
| 0.2 |
0.4 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.2 |
3.6 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.2 |
1.3 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
0.2 |
GO:0072537 |
fibroblast activation(GO:0072537) |
| 0.2 |
0.8 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.2 |
1.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.2 |
5.0 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
0.2 |
GO:0090403 |
negative regulation of icosanoid secretion(GO:0032304) oxidative stress-induced premature senescence(GO:0090403) |
| 0.2 |
0.8 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.2 |
1.5 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.2 |
1.7 |
GO:0021815 |
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
| 0.2 |
0.6 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.2 |
3.3 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.2 |
0.8 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.2 |
1.0 |
GO:0071872 |
cellular response to epinephrine stimulus(GO:0071872) |
| 0.2 |
0.8 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.2 |
0.2 |
GO:0046959 |
habituation(GO:0046959) |
| 0.2 |
2.5 |
GO:0097205 |
renal filtration(GO:0097205) |
| 0.2 |
1.4 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 |
1.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
2.7 |
GO:0001738 |
establishment of planar polarity(GO:0001736) morphogenesis of a polarized epithelium(GO:0001738) establishment of tissue polarity(GO:0007164) |
| 0.2 |
1.8 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.2 |
11.8 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 |
0.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.2 |
0.6 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 |
1.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
11.8 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.2 |
1.4 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.2 |
2.8 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.2 |
2.6 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
2.2 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
1.0 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
1.2 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 |
1.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.2 |
0.4 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 |
1.6 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
0.4 |
GO:0060936 |
cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.2 |
1.4 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
| 0.2 |
1.2 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.2 |
1.2 |
GO:0070778 |
L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.2 |
0.4 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.2 |
0.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
8.8 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 |
2.4 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 |
1.0 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 |
0.8 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.2 |
3.1 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 |
0.8 |
GO:0007097 |
nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.2 |
1.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
0.4 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.2 |
0.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
5.0 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
0.8 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.2 |
1.5 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
| 0.2 |
0.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.2 |
0.2 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.2 |
0.9 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.2 |
5.5 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.2 |
0.9 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.2 |
3.8 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.2 |
2.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 |
16.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
16.2 |
GO:0071427 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.2 |
0.2 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.2 |
0.6 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 |
7.0 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.2 |
1.5 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.2 |
2.2 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.2 |
2.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
2.4 |
GO:0030210 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 |
2.7 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.2 |
0.4 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 |
6.2 |
GO:0051058 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.2 |
1.1 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
1.6 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.2 |
0.7 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 |
1.1 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.2 |
0.9 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
2.2 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.2 |
0.2 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.2 |
2.5 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
1.1 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.2 |
1.2 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.2 |
3.7 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.2 |
0.7 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
0.5 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.2 |
1.9 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.2 |
1.2 |
GO:0007623 |
circadian rhythm(GO:0007623) |
| 0.2 |
1.0 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.2 |
2.6 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 |
1.7 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
0.7 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 |
3.4 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.2 |
1.2 |
GO:0033044 |
regulation of chromosome organization(GO:0033044) |
| 0.2 |
0.7 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.2 |
7.8 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.2 |
0.3 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
0.2 |
GO:0090298 |
base-excision repair, DNA ligation(GO:0006288) regulation of mitochondrial DNA replication(GO:0090296) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.2 |
1.0 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
3.7 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 |
0.8 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.2 |
0.5 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 |
0.5 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.2 |
3.1 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.2 |
0.7 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.2 |
1.0 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 |
1.0 |
GO:0051918 |
regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
| 0.2 |
1.2 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.2 |
7.2 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.2 |
0.3 |
GO:0050891 |
multicellular organismal water homeostasis(GO:0050891) |
| 0.2 |
2.0 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.2 |
1.5 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.2 |
0.2 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.2 |
0.5 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.8 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.2 |
2.1 |
GO:0061072 |
iris morphogenesis(GO:0061072) |
| 0.2 |
0.3 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.2 |
0.5 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.2 |
2.4 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.2 |
2.2 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 |
6.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.2 |
0.5 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
0.6 |
GO:0044417 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.2 |
0.5 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.2 |
0.6 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 |
0.8 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.2 |
1.4 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 |
0.8 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 |
2.3 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.2 |
2.0 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.2 |
0.9 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.2 |
0.3 |
GO:0032909 |
transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.2 |
0.2 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.2 |
0.3 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.2 |
1.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 |
2.1 |
GO:0032743 |
positive regulation of interleukin-2 production(GO:0032743) |
| 0.2 |
0.2 |
GO:0090224 |
regulation of spindle organization(GO:0090224) |
| 0.1 |
1.6 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.3 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.7 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.7 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) |
| 0.1 |
19.0 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.1 |
0.4 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
3.3 |
GO:2001273 |
regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 |
0.4 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.7 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.1 |
0.4 |
GO:1903059 |
regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) regulation of protein lipidation(GO:1903059) negative regulation of protein lipidation(GO:1903060) |
| 0.1 |
1.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.6 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 |
0.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.6 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
1.0 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.6 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.1 |
1.0 |
GO:0044117 |
growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 0.1 |
1.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
3.7 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 |
1.0 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 |
0.6 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
1.8 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.4 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.1 |
2.1 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 |
1.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
1.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
0.7 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.6 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 0.1 |
1.2 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.5 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.1 |
2.5 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
3.0 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
1.8 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
1.6 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
1.8 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
0.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
0.4 |
GO:0009452 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.7 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
0.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.5 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
7.0 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.5 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
2.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.1 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
3.2 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.1 |
0.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.5 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
2.9 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 |
0.3 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
0.9 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 |
0.4 |
GO:0071106 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 |
0.6 |
GO:0070072 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
1.0 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.1 |
1.3 |
GO:0042384 |
cilium assembly(GO:0042384) |
| 0.1 |
1.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
1.2 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
0.1 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 |
0.5 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.5 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 |
4.9 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
1.9 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.1 |
0.8 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
2.1 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.1 |
0.8 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.2 |
GO:0050820 |
positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.1 |
4.1 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.1 |
0.4 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.7 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.2 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.5 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.1 |
0.6 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.1 |
0.2 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.1 |
0.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
1.1 |
GO:0061726 |
mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.1 |
0.3 |
GO:0010661 |
positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
2.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
1.9 |
GO:0046850 |
regulation of bone remodeling(GO:0046850) |
| 0.1 |
1.2 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.5 |
GO:1990736 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 0.1 |
0.2 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.2 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.1 |
0.2 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.1 |
0.9 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 |
1.4 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 |
2.2 |
GO:0014059 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
2.1 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.7 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.9 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 |
0.8 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.2 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 |
0.4 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.8 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
1.8 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.7 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
1.2 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.1 |
0.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.5 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.5 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.1 |
0.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
5.9 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
0.4 |
GO:0009651 |
response to salt stress(GO:0009651) |
| 0.1 |
0.1 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.1 |
0.1 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
0.5 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.1 |
0.3 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 |
1.9 |
GO:0002251 |
organ or tissue specific immune response(GO:0002251) |
| 0.1 |
0.3 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
2.7 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
1.3 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
1.4 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
5.2 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
1.2 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.4 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
1.1 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.1 |
1.8 |
GO:0030518 |
intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.3 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 |
1.6 |
GO:1901224 |
positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.1 |
0.3 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 |
0.4 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 |
1.2 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
0.4 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.5 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
1.1 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
5.1 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.3 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
1.2 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
9.5 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 |
0.9 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
3.1 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.3 |
GO:0072141 |
renal interstitial fibroblast development(GO:0072141) |
| 0.1 |
6.5 |
GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 |
4.3 |
GO:1905037 |
autophagosome organization(GO:1905037) |
| 0.1 |
0.5 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 |
0.4 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.8 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.1 |
0.4 |
GO:0044839 |
cell cycle G2/M phase transition(GO:0044839) |
| 0.1 |
0.4 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
0.4 |
GO:0035822 |
gene conversion(GO:0035822) |
| 0.1 |
1.1 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.7 |
GO:0002739 |
regulation of cytokine secretion involved in immune response(GO:0002739) |
| 0.1 |
0.3 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 |
0.5 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.3 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 |
0.5 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
4.7 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
3.4 |
GO:0006306 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 |
0.4 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
1.0 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.1 |
0.5 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 0.1 |
0.3 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.1 |
1.7 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.2 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.4 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.1 |
0.7 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
0.7 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.3 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 |
1.0 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.1 |
1.4 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
2.5 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 |
0.2 |
GO:1901053 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
0.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.2 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 |
0.1 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.5 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 |
2.7 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.1 |
0.9 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.2 |
GO:0042701 |
progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
| 0.1 |
0.9 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) |
| 0.1 |
0.5 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.2 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
3.8 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 |
3.7 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.1 |
GO:0043497 |
regulation of protein heterodimerization activity(GO:0043497) |
| 0.1 |
1.7 |
GO:0044247 |
glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.2 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.1 |
0.4 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.2 |
GO:0071317 |
cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 |
0.4 |
GO:0010166 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.6 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
2.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.4 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.5 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.5 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.1 |
0.2 |
GO:0006489 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.1 |
0.8 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.1 |
0.1 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
0.2 |
GO:0070586 |
cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 |
0.7 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.1 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.1 |
0.3 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
0.8 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.1 |
0.6 |
GO:0009067 |
aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.1 |
0.3 |
GO:0051261 |
protein depolymerization(GO:0051261) |
| 0.1 |
0.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.1 |
0.3 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.6 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
1.5 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.3 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 |
2.2 |
GO:0042102 |
positive regulation of T cell proliferation(GO:0042102) |
| 0.1 |
0.7 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.4 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
4.5 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.1 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.9 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
1.1 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.1 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.5 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.1 |
0.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.5 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
0.2 |
GO:0031644 |
regulation of neurological system process(GO:0031644) |
| 0.1 |
0.2 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 |
0.1 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.9 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
1.0 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.2 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.1 |
1.7 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.8 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
0.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.2 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.1 |
0.1 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.1 |
0.1 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 |
1.1 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.1 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 |
0.8 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.1 |
GO:0072350 |
tricarboxylic acid metabolic process(GO:0072350) |
| 0.1 |
0.4 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.1 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.2 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.1 |
0.3 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 |
0.3 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.7 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 |
0.3 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.4 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.0 |
0.3 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 |
0.2 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.0 |
0.2 |
GO:2000145 |
regulation of cell motility(GO:2000145) |
| 0.0 |
7.6 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
1.7 |
GO:0002456 |
T cell mediated immunity(GO:0002456) |
| 0.0 |
0.5 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.4 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 |
0.0 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
1.1 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.0 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
0.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.3 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.2 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 |
0.3 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 |
0.2 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 |
0.5 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 |
0.6 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
1.1 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.4 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.0 |
0.3 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 |
0.1 |
GO:1901985 |
positive regulation of protein acetylation(GO:1901985) |
| 0.0 |
0.3 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.5 |
GO:1902593 |
single-organism nuclear import(GO:1902593) |
| 0.0 |
0.6 |
GO:0046605 |
regulation of centrosome cycle(GO:0046605) |
| 0.0 |
0.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.0 |
GO:0006267 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.1 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
1.0 |
GO:0034333 |
adherens junction assembly(GO:0034333) |
| 0.0 |
0.3 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.0 |
0.1 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.0 |
0.1 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.0 |
0.3 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.1 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 |
0.2 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.4 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.1 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.2 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
0.1 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.9 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.0 |
0.2 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.0 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.8 |
GO:0016197 |
endosomal transport(GO:0016197) |
| 0.0 |
0.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.0 |
0.1 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.0 |
0.0 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
0.0 |
GO:0009451 |
RNA modification(GO:0009451) |
| 0.0 |
0.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.8 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.0 |
0.2 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.1 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.0 |
0.1 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.1 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.2 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
0.3 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.6 |
GO:0043242 |
negative regulation of protein complex disassembly(GO:0043242) |
| 0.0 |
0.5 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.0 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.0 |
0.2 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.1 |
GO:2000391 |
positive regulation of neutrophil extravasation(GO:2000391) |
| 0.0 |
0.0 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.0 |
0.0 |
GO:0000278 |
mitotic cell cycle(GO:0000278) |
| 0.0 |
0.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.2 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.1 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.1 |
GO:0052027 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.0 |
0.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.0 |
GO:0098728 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 |
0.1 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.0 |
0.4 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 |
0.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.0 |
GO:1904180 |
negative regulation of membrane depolarization(GO:1904180) |
| 0.0 |
0.1 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0006833 |
water transport(GO:0006833) |